BioLargo, Inc.: BioLargo says current projects are “major growth catalysts,” as it shares updates with investors

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Friday, 18 February 2022

BioLargo says current projects are “major growth catalysts,” as it shares updates with investors

Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/974546/biolargo-says-current-projects-are-major-growth-catalysts-as-it-shares-updates-with-investors-974546.html)

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert joined Proactive's Stephen Gunnion with update on three key projects that he says are major growth catalysts for the company.

Calvert telling Proactive that BioLargo's disruptive solutions have the potential to build significant value for the company and its shareholders, resulting in increased attention from the market.

Friday, 18 February 2022

BioLargo says current projects are “major growth catalysts,” as it shares updates with investors

No comments:

Post a Comment